11 Results

People

  1. Tallman
    Tallman
  2. Derkach
    Derkach
  3. Abdel-Wahab
    Abdel-Wahab
  4. Famulare
    Famulare
  5. Goldberg
    Goldberg
  6. Levine
    Levine
  7. Park
    Park
  8. Roshal
    Roshal
  9. Stein
    Stein
  10. Cai
    Cai

Groups

  1. Adult Leukemia (11)
  2. Biostatistics Service (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Epidemiology and Biostatistics (11)
  6. Hematologic Malignancies, Division of (11)
  7. Population Sciences Research Program (8)
  8. Executive Committee, Center for Hematologic Malignancies (5)
  9. GSK Faculty (5)
  10. Human Oncology and Pathogenesis Program (5)
  1. "Martin Tallman"
  2. "Biostatistics Service"
  3. "American Society of Hematology"
  4. "Journal article"
Formats
  1. Journal Article (11)
Groups
  1. Adult Leukemia (11)
  2. Biostatistics Service (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Epidemiology and Biostatistics (11)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Martin Tallman (11)
  2. Andriy Derkach (6)
  3. Jae Park (6)
  4. Aaron Goldberg (4)
  5. Christopher Famulare (4)
  6. Eytan Stein (4)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (1)
  5. 2017 (2)
  6. 2012 (1)

More Years

Publications
  1. Blood (7)
  2. Blood Advances (4)
Publishers
  1. American Society of Hematology (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy
    Journal Article

    Handa, S.; Lee, J. O.; Derkach, A.; Stone, R. M.; Saven, A.; Altman, J. K.; Grever, M. R.; Rai, K. R.; Shukla, M.; Vemuri, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
    Journal Article

    Epstein-Peterson, Z. D.; Derkach, A.; Geyer, S.; Mrózek, K.; Kohlschmidt, J.; Park, J. H.; Rajeeve, S.; Stein, E. M.; Zhang, Y.; Iland, H.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
    Journal Article

    Xiao, W.; Chan, A.; Waarts, M. R.; Mishra, T.; Liu, Y.; Cai, S. F.; Yao, J.; Gao, Q.; Bowman, R. L.; Koche, R. P.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
    Journal Article

    Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis
    Journal Article

    Geyer, M. B.; Hsu, M.; Devlin, S. M.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
    Journal Article

    Mantha, S.; Goldman, D. A.; Devlin, S. M.; Lee, J. W.; Zannino, D.; Collins, M.; Douer, D.; Iland, H. J.; Litzow, M. R.; Stein, E. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
    Journal Article

    Gonen, M.; Sun, Z.; Figueroa, M. E.; Patel, J. P.; Abdel-Wahab, O.; Racevskis, J.; Ketterling, R. P.; Fernandez, H.; Rowe, J. M.; Tallman, M. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
    Journal Article

    Park, J. H.; Qiao, B.; Panageas, K. S.; Schymura, M. J.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2011)

    Fulltext@MSK | Save